down arrow

Natco Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
767.90
21.05 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
3,998.80
2,707.10
1,944.80
2,052.10
1,915.00
2,094.50
2,184.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,998.80
2,707.10
1,944.80
2,052.10
1,915.00
2,094.50
2,184.80
Raw Material Cost
522.50
475.30
519.20
372.90
329.00
333.10
390.50
Purchase of Finished goods
151.40
175.70
58.50
186.60
127.80
55.00
45.90
(Increase) / Decrease In Stocks
42.70
-23.70
-16.80
-48.10
-75.20
-33.90
-25.30
Employee Cost
525.00
486.70
444.80
414.90
375.00
355.90
325.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,005.80
657.50
675.60
519.60
575.80
589.60
519.70
Total Expenditure (Excl Depreciation)
2,247.40
1,771.50
1,681.30
1,445.90
1,332.40
1,299.70
1,256.40
Operating Profit (PBDIT) excl Other Income
1,751.40
935.60
263.50
606.20
582.60
794.80
928.40
Other Income
128.10
104.60
99.00
103.60
107.40
130.20
40.40
Operating Profit (PBDIT)
1,879.50
1,040.20
362.50
709.80
690.00
925.00
968.80
Interest
19.20
14.50
17.70
13.30
21.50
19.30
15.40
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,860.30
1,025.70
344.80
696.50
668.50
905.70
953.40
Depreciation
186.80
163.80
142.60
116.90
99.80
81.00
66.20
Profit Before Tax
1,673.50
861.90
202.20
579.60
568.70
824.70
887.20
Tax
285.20
146.60
32.20
137.20
110.60
182.30
192.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,388.30
715.30
170.00
442.40
458.10
642.40
695.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,388.30
715.30
170.00
442.40
458.10
642.40
695.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-1.50
2.70
2.00
1.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,388.30
715.30
170.00
440.90
460.80
644.40
696.20
Equity Capital
35.80
36.50
36.50
36.50
36.40
36.50
36.90
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
5,817.30
4,837.30
4,227.10
4,085.10
3,737.10
3,452.50
3,035.30
Earnings per share (EPS)
77.56
39.19
9.32
24.16
25.32
35.31
37.73
Diluted Earnings per share
77.34
39.18
9.32
24.16
25.26
34.87
39.13
Operating Profit Margin (Excl OI)
43.8%
34.56%
13.55%
29.54%
30.42%
37.95%
42.49%
Gross Profit Margin
46.52%
37.89%
17.73%
33.94%
34.91%
43.24%
43.64%
PAT Margin
34.72%
26.42%
8.74%
21.56%
23.92%
30.67%
31.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 87.20% vs 255.07% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 32.41% vs -18.08% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Natco Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,998.80
10,334.77
-6,335.97
-61.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,998.80
10,334.77
-6,335.97
-61.31%
Raw Material Cost
522.50
1,853.52
-1,331.02
-71.81%
Purchase of Finished goods
151.40
1,409.85
-1,258.45
-89.26%
(Increase) / Decrease In Stocks
42.70
-53.67
96.37
179.56%
Employee Cost
525.00
2,274.73
-1,749.73
-76.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,005.80
2,315.28
-1,309.48
-56.56%
Total Expenditure (Excl Depreciation)
2,247.40
7,799.71
-5,552.31
-71.19%
Operating Profit (PBDIT) excl Other Income
1,751.40
2,535.06
-783.66
-30.91%
Other Income
128.10
280.86
-152.76
-54.39%
Operating Profit (PBDIT)
1,879.50
2,815.92
-936.42
-33.25%
Interest
19.20
33.53
-14.33
-42.74%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,860.30
2,782.39
-922.09
-33.14%
Depreciation
186.80
398.25
-211.45
-53.09%
Profit Before Tax
1,673.50
2,384.14
-710.64
-29.81%
Tax
285.20
457.58
-172.38
-37.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,388.30
1,926.56
-538.26
-27.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,388.30
1,926.56
-538.26
-27.94%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,388.30
1,912.90
-524.60
-27.42%
Equity Capital
35.80
40.06
-4.26
-10.63%
Face Value
2.00
1.00
0.00
Reserves
5,817.30
9,323.03
-3,505.73
-37.60%
Earnings per share (EPS)
77.56
47.75
29.81
62.43%
Diluted Earnings per share
77.34
47.68
29.66
62.21%
Operating Profit Margin (Excl OI)
43.80%
24.53%
0.00
19.27%
Gross Profit Margin
46.52%
26.92%
0.00
19.60%
PAT Margin
34.72%
18.79%
0.00
15.93%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 3,998.80 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1,388.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,751.40 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 87.20% vs 255.07% in Mar 2023

Annual - Interest
Interest 19.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 32.41% vs -18.08% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 43.80%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023